Testing effectiveness (Phase 2)Looking for participantsNCT04106115
What this trial is testing
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
Who this might be right for
Bladder Cancer
University College, London 52